Executive Development Programme in Pharma Ethics for the C-Suite
-- ViewingNowThe Executive Development Programme in Pharma Ethics for the C-Suite is a certificate course designed to empower senior executives with a deep understanding of pharmaceutical ethics. In an industry where ethical conduct is paramount, this program provides crucial training in navigating complex ethical scenarios, ensuring regulatory compliance, and fostering a culture of integrity.
3,306+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ๅ ณไบ่ฟ้จ่ฏพ็จ
100%ๅจ็บฟ
้ๆถ้ๅฐๅญฆไน
ๅฏๅไบซ็่ฏไนฆ
ๆทปๅ ๅฐๆจ็LinkedInไธชไบบ่ตๆ
2ไธชๆๅฎๆ
ๆฏๅจ2-3ๅฐๆถ
้ๆถๅผๅง
ๆ ็ญๅพ ๆ
่ฏพ็จ่ฏฆๆ
โข
Pharma Ethical Leadership: This unit covers the importance of ethical leadership in the pharmaceutical industry and how C-Suite executives can promote a culture of ethics within their organizations.
โข
Compliance with Pharma Regulations: This unit focuses on the various regulations that govern the pharmaceutical industry, including the FDA, EMA, and MHRA, and the importance of compliance for C-Suite executives.
โข
Pharma Ethical Marketing Practices: This unit discusses the ethical considerations in pharmaceutical marketing, including the promotion of off-label use, and how C-Suite executives can ensure their marketing teams are following ethical guidelines.
โข
Pharma Clinical Trials and Ethics: This unit covers the ethical considerations in clinical trials, including informed consent, data integrity, and patient safety, and how C-Suite executives can ensure their clinical trials are conducted ethically.
โข
Pharma Pricing and Accessibility: This unit explores the ethical implications of pharmaceutical pricing, including the impact on patients and healthcare systems, and how C-Suite executives can develop pricing strategies that balance profitability with accessibility.
โข
Pharma Lobbying and Political Contributions: This unit examines the ethical considerations surrounding pharmaceutical lobbying and political contributions, and how C-Suite executives can ensure their companies are engaging in these activities ethically and transparently.
โข
Pharma Intellectual Property and Patent Ethics: This unit discusses the ethical considerations around pharmaceutical intellectual property and patents, including issues related to evergreening and access to generic drugs, and how C-Suite executives can ensure their companies are handling these matters ethically.
โข
Pharma Whistleblower Protections and Reporting Mechanisms: This unit covers the importance of protecting whistleblowers and providing reporting mechanisms for ethical concerns, and how C-Suite executives can ensure their companies have robust systems in place to encourage reporting and prevent retaliation.
โข
Pharma Supply
่ไธ้่ทฏ
ๅ ฅๅญฆ่ฆๆฑ
- ๅฏนไธป้ข็ๅบๆฌ็่งฃ
- ่ฑ่ฏญ่ฏญ่จ่ฝๅ
- ่ฎก็ฎๆบๅไบ่็ฝ่ฎฟ้ฎ
- ๅบๆฌ่ฎก็ฎๆบๆ่ฝ
- ๅฎๆ่ฏพ็จ็ๅฅ็ฎ็ฒพ็ฅ
ๆ ้ไบๅ ็ๆญฃๅผ่ตๆ ผใ่ฏพ็จ่ฎพ่ฎกๆณจ้ๅฏ่ฎฟ้ฎๆงใ
่ฏพ็จ็ถๆ
ๆฌ่ฏพ็จไธบ่ไธๅๅฑๆไพๅฎ็จ็็ฅ่ฏๅๆ่ฝใๅฎๆฏ๏ผ
- ๆช็ป่ฎคๅฏๆบๆ่ฎค่ฏ
- ๆช็ปๆๆๆบๆ็็ฎก
- ๅฏนๆญฃๅผ่ตๆ ผ็่กฅๅ
ๆๅๅฎๆ่ฏพ็จๅ๏ผๆจๅฐ่ทๅพ็ปไธ่ฏไนฆใ
ไธบไปไนไบบไปฌ้ๆฉๆไปฌไฝไธบ่ไธๅๅฑ
ๆญฃๅจๅ ่ฝฝ่ฏ่ฎบ...
ๅธธ่ง้ฎ้ข
่ฏพ็จ่ดน็จ
- ๆฏๅจ3-4ๅฐๆถ
- ๆๅ่ฏไนฆไบคไป
- ๅผๆพๆณจๅ - ้ๆถๅผๅง
- ๆฏๅจ2-3ๅฐๆถ
- ๅธธ่ง่ฏไนฆไบคไป
- ๅผๆพๆณจๅ - ้ๆถๅผๅง
- ๅฎๆด่ฏพ็จ่ฎฟ้ฎ
- ๆฐๅญ่ฏไนฆ
- ่ฏพ็จๆๆ
่ทๅ่ฏพ็จไฟกๆฏ
่ทๅพ่ไธ่ฏไนฆ
